Document is current
Any future updates will be listed below
-
Authors
Wang, Yuqing https://orcid.org/0000-0003-3903-8367
Du, Jun https://orcid.org/0000-0002-1686-6226
Lu, Shanshan https://orcid.org/0000-0001-7645-9377
Li, Xia https://orcid.org/0000-0003-4181-576X
Chen, Yifei
Yuan, Chao
Hou, Sheng-Tao
Wang, Yizheng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81871026)
Shenzhen Science and Technology Innovation Commission (JCYJ20180504165806229, KQJSCX20180322151111754)
Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions
- License Information
-
More Information
Article History
Received: 9 September 2021
Revised: 12 January 2022
Accepted: 16 January 2022
First Online: 23 March 2022
Competing interests
: Y.Q.W., S.S.L., and Y.Z.W. are co-inventors of the patent application (201910958144.0) ‘A peptide in the treatment of ischemic stroke’.
